Letters to the editorClopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study☆
Section snippets
Acknowledgements
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [8].
References (8)
- et al.
High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) randomized study
J Am Coll Cardiol
(2011) - et al.
Ethics in the authorship and publishing of scientific articles
Int J Cardiol
(2010) - et al.
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up
Circulation
(2009) - et al.
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation
Eur Heart J
(2008)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This work was supported by Research Project no. IGA NS 9988-4/2008.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.